Compare Nippon Indosari Corpindo Tbk. (ROTI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nippon Indosari Corpindo Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Nippon Indosari Corpindo Tbk. trades at Rp585 (market cap 3.62T, 583.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 34.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ROTI | SCPI | |
|---|---|---|
Market Cap | 3.62T | 104.4B |
Volume | 583.1K | — |
Lot | 5.83K | — |
Turnover | 340.99M | — |
Average Price | 584.79 | — |
Value | 340.99M | — |
Indicative Equilibrium Price | 585 | — |
Indicative Equilibrium Volume | 1.81K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nippon Indosari Corpindo Tbk.
PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
